Resistant systemic hypertension

Journal of Cardiovascular Medicine

Volumn 12, Issue 5, 2011, Pages 340-342

  Al Baba, Bassam ^a  

^a Department of Cardiology   (Syrian Arab Republic)

Author keywords

coarctation of aorta; hypertension; licorice juice; obstructive sleep apnea; renal denervation; resistant hypertension

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CHLORTALIDONE; COCAINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; DECONGESTIVE AGENT; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ESTROGEN; FUROSEMIDE; GLUCOCORTICOID; GLYCYRRHETINIC ACID; HERBACEOUS AGENT; METHAMPHETAMINE; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; UNINDEXED DRUG;

ADD ON THERAPY; ANTIHYPERTENSIVE THERAPY; AORTA COARCTATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID SINUS PRESSORECEPTOR; CHRONIC KIDNEY DISEASE; DIURETIC THERAPY; DRUG DOSE TITRATION; FIBROMUSCULAR DYSPLASIA; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DENERVATION; MIDDLE EAST; PATIENT COMPLIANCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIMARY HYPERALDOSTERONISM; RESISTANT HYPERTENSION; SLEEP APNEA SYNDROME; SYRIAN ARAB REPUBLIC; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TREATMENT FAILURE;

EID: 79955441829     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328343e9e0     Document Type: Article

References (10)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
2. Egan, BM, Zhao, Y, Rehman, SU, Brzezinski WA, Clyburn B, Basile JN, et al. Treatment resistant hypertension in a community-based practice network (abstract). J Clin Hypertens (Greenwich) 2009; OR-12:A6.
3. Goncalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007; 132:1858-1862.
4. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19:2271-2277. (Pubitemid 33135251)
5. Amar J, Chamontin B, Genes N, Cantet C, Salvador M, Cambou JP. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens 2003; 21:1199-1205. (Pubitemid 36667875)
6. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 2008; 168:1159-1164. (Pubitemid 351831398)
7. Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 2005; 18:1534-1540. (Pubitemid 41814672)
8. Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med 2009; 361:1972-1978.
9. Schlaich MP, Sabotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361:932-934.
10. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M, Simplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Simplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376:1903-1909.